MedPath

Intraoperative IV Iron on Postoperative Red Blood Cell Recovery

Phase 4
Conditions
Osteoarthritis, Hip
Interventions
Registration Number
NCT04035902
Lead Sponsor
Konkuk University Medical Center
Brief Summary

The objective of the present study is to determine the impact of intraoperative IV-iron supplementation on postoperative recovery of RBC mass by retrospectively analyzing and comparing the changes of postoperative hematocrit values after the surgery in patients underwent elective uni-limb total knee arthroplasty surgery with or without IV-iron supplementation during surgery

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controlcontrolFerric carboxymaltose is not administered
ferric carboxymaltose 1000 mgFerric carboxymaltoseFerric carboxymaltose is administered during surgery
Primary Outcome Measures
NameTimeMethod
postoperative hematocrit (%)7 days after surgery

hematocrit is evaluated on postoperative 7 days

Secondary Outcome Measures
NameTimeMethod
volume of post-operative bleeding (ml)7 day

total volume of postoperative bleeding collected in the drainage container (hemovac)

intraoperative blood transfusion (ml)1 day

total volume of intraoperative blood transfusion

post-operative blood transfusion (ml)7 days

total amount of post-operative blood transfusion (ml)

post-operative serum ferritin level (ng/ml)1 day

post-operative serum ferritin level (ng/ml) is checked immediately after surgery

© Copyright 2025. All Rights Reserved by MedPath